Cargando…

Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice

AIMS/HYPOTHESIS: Several lines of evidence suggest that incretin-based therapies suppress the development of cardiovascular disease in type 2 diabetes. We investigated the possibility that glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) can prevent the developm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagashima, M., Watanabe, T., Terasaki, M., Tomoyasu, M., Nohtomi, K., Kim-Kaneyama, J., Miyazaki, A., Hirano, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168747/ https://www.ncbi.nlm.nih.gov/pubmed/21786155 http://dx.doi.org/10.1007/s00125-011-2241-2

Ejemplares similares

Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
por: Terasaki, Michishige, et al.
Publicado: (2013)

Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice
por: Nogi, Yukinori, et al.
Publicado: (2012)

Apolipoprotein E knockout rabbit model of intracranial atherosclerotic disease
por: Zabriskie, Matthew S., et al.
Publicado: (2020)

FRI107 Ketogenic Diet Prevents Development Of Atherosclerotic Plaques In Apolipoprotein E Knockout Mice
por: Marzolla, Vincenzo, et al.
Publicado: (2023)

Natural Killer T Cells Are Involved in Atherosclerotic Plaque Instability in Apolipoprotein-E Knockout Mice
por: Ohmura, Yoshinori, et al.
Publicado: (2021)

15-Deoxy-Δ(12,14) Prostaglandin J(2) Reduces the Formation of Atherosclerotic Lesions in Apolipoprotein E Knockout Mice
por: Seno, Takahiro, et al.
Publicado: (2011)

The Fat-Fed Apolipoprotein E Knockout Mouse Brachiocephalic Artery in the Study of Atherosclerotic Plaque Rupture
por: Bond, Andrew R., et al.
Publicado: (2011)

Reduced Atherosclerotic Lesion Size in P-Selectin Deficient Apolipoprotein E-Knockout Mice Fed a Chow but Not a Fat Diet
por: Bourdillon, Marie-Claude, et al.
Publicado: (2006)

Medial Expression of TNF-α and TNF Receptors Precedes the Development of Atherosclerotic Lesions in Apolipoprotein E/LDL Receptor Double Knockout Mice
por: Niemann-Jönsson, Audrey, et al.
Publicado: (2007)

Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E–knockout mice
por: Li, Gang, et al.
Publicado: (2014)

Untargeted Lipidomic Profiling Reveals Lysophosphatidylcholine and Ceramide as Atherosclerotic Risk Factors in apolipoprotein E Knockout Mice
por: Law, Shi-Hui, et al.
Publicado: (2023)

2-Hydroxypropyl-beta-cyclodextrin Treatment Does Not Induce Atherosclerotic Lesion Regression in Western-Type Diet-Fed Apolipoprotein E Knockout Mice
por: Snip, Olga S.C., et al.
Publicado: (2022)

SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis †
por: Terasaki, Michishige, et al.
Publicado: (2023)

Perforin and Granzyme B Have Separate and Distinct Roles during Atherosclerotic Plaque Development in Apolipoprotein E Knockout Mice
por: Hiebert, Paul R., et al.
Publicado: (2013)

The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis
por: Kadoglou, N.P.E., et al.
Publicado: (2013)

Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using (111)In-tilmanocept
por: Varasteh, Zohreh, et al.
Publicado: (2017)

Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes
por: Kanter, Jenny E., et al.
Publicado: (2020)

Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice
por: Yang, Jian Min, et al.
Publicado: (2011)

ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions
por: Mantani, Polyxeni T., et al.
Publicado: (2019)

Vitamin D Deficiency and Exogenous Vitamin D Excess Similarly Increase Diffuse Atherosclerotic Calcification in Apolipoprotein E Knockout Mice
por: Ellam, Timothy, et al.
Publicado: (2014)

Sildenafil restores endothelial function in the apolipoprotein E knockout mouse
por: Balarini, Camille M, et al.
Publicado: (2013)

Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases
por: Kigawa, Yasuyoshi, et al.
Publicado: (2017)

Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice
por: Li, Bo, et al.
Publicado: (2016)

Protease-Activated Receptor-2 Deficiency Attenuates Atherosclerotic Lesion Progression and Instability in Apolipoprotein E-Deficient Mice
por: Zuo, Pengfei, et al.
Publicado: (2017)

Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using (68)Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques
por: Varasteh, Zohreh, et al.
Publicado: (2019)

Dietary Egg Sphingomyelin Prevents Aortic Root Plaque Accumulation in Apolipoprotein-E Knockout Mice
por: Millar, Courtney L., et al.
Publicado: (2019)

Age-Related Changes in the Behavior of Apolipoprotein E Knockout Mice
por: Fuentes, Dasha, et al.
Publicado: (2018)

Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice
por: Watson, Anna M.D., et al.
Publicado: (2012)

Anti-Atherosclerotic Action of Agmatine in ApoE-Knockout Mice
por: Wiśniewska, Anna, et al.
Publicado: (2017)

Secreted IL-1Ra exerts a protective effect on atherosclerotic lesion development in apolipoprotein-E-deficient mice
por: Soussi, F, et al.
Publicado: (2003)

Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor
por: Sun, Hui, et al.
Publicado: (2015)

Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice
por: Preusch, Michael R, et al.
Publicado: (2015)

The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice
por: Stachowicz, Aneta, et al.
Publicado: (2019)

The Complementary Effects of Dabigatran Etexilate and Exercise Training on the Development and Stability of the Atherosclerotic Lesions in Diabetic ApoE Knockout Mice
por: Kadoglou, Nikolaos PE, et al.
Publicado: (2023)

Anti-atherosclerotic effect of incretin mimetics: a meta-analysis of randomized controlled trials
por: Barbarawi, Mahmoud, et al.
Publicado: (2018)

Moxibustion at CV4 alleviates atherosclerotic lesions through activation of the LXRα/ABCA1 pathway in apolipoprotein-E-deficient mice
por: Cui, Yingxue, et al.
Publicado: (2019)

Caspase-3 Deletion Promotes Necrosis in Atherosclerotic Plaques of ApoE Knockout Mice
por: Grootaert, Mandy O. J., et al.
Publicado: (2016)

Effect of hyperlipidemia on the expression of circadian genes in apolipoprotein E knock-out atherosclerotic mice
por: Hou, Likun, et al.
Publicado: (2009)

Local Gene Silencing of Monocyte Chemoattractant Protein-1 Prevents Vulnerable Plaque Disruption in Apolipoprotein E-Knockout Mice
por: Liu, Xiao Ling, et al.
Publicado: (2012)

Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse
por: Williams, Helen, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qcf4nn9sbmb53k1bmtekma5ktr